4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0000921895-26-001639
Options or other derivatives
- Director acquired 22,195 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL Director | 2026-06-17 | Grant or award · Option to Buy | +22,195 | 22,195 | I: show line 1 in the form |
Loading xslF345X06/form407422mltx_06222026.xml…